05/29/2026
🌍 TriAxis Biosciences participated in the IDSA/ASM Clinician Call: Key Updates on Hantavirus & Ebola.
As emerging infectious diseases continue to challenge health systems globally, staying connected with frontline clinical updates is essential. Today’s session brought together leading experts from IDSA, ASM, CEID, Boston University, Emory University, George Washington University, and the University of Nebraska to discuss:
🦠 Hantavirus diagnostics and laboratory preparedness
🏥 Clinical management and infection prevention
🌍 Ebola epidemiology and the current global situation
🛡️ Preparedness implications for clinicians and public health systems
For TriAxis Biosciences, this discussion strongly connects with our mission: using biosciences, computational biology, AI, and infectious disease surveillance to support earlier detection, better preparedness, and stronger public health decision-making.
One key takeaway: infectious disease preparedness is not only about responding after an outbreak begins. It is about building systems that can detect signals early, connect clinical and environmental data, and help communities act before threats become larger crises.
At TriAxis Biosciences, we are especially interested in how emerging tools such as wastewater surveillance, genomic monitoring, antimicrobial resistance tracking, and AI-driven analytics can strengthen the future of outbreak preparedness.
💬 Question for clinicians, researchers, and public health professionals:
What do you think is the biggest gap today in infectious disease preparedness - early detection, laboratory capacity, data integration, clinical training, or public health coordination?
We would love to hear your thoughts.
